Clinical Trials Browser

Terminated × INDUSTRY × Oligodendroglioma × Clear all

Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT06038760 2025-07-30

PEAR-GLIO

Terminated

12 enrolled

CNS

Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Neoplasms, Oligodendroglioma

NCT05737212 2025-02-21

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Phase 1/2 Terminated

7 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

NCT01986348 2023-01-26

KING

Phase 2 Terminated

76 enrolled 16 charts

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT04327011 2020-03-30

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

Phase 1 Terminated

65 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT02764151 2020-01-27

First in Patient Study for PF-06840003 in Malignant Gliomas

Phase 1 Terminated

17 enrolled 35 charts

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT00389090 2012-02-09

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Phase 2 Terminated

32 enrolled

CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT00062504 2011-05-23

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas

Phase 2 Terminated

30 enrolled

CNS

Astrocytoma, Glioblastoma, Oligodendroglioma

Clinical Trials

FIGHT-209

PEAR-GLIO

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

KING

A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511

First in Patient Study for PF-06840003 in Malignant Gliomas

A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma

Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas